FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1297003005: Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Dec 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5288162019 Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5288163012 Codeine phosphate 15 mg and paracetamol 500 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5288164018 Acetaminophen 500 mg and codeine phosphate 15 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Is a Product containing only codeine and paracetamol in oral dose form (medicinal product form) true Inferred relationship Some
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has manufactured dose form Oral capsule true Inferred relationship Some
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role Antitussive therapeutic role (role) true Inferred relationship Some
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Codeine phosphate true Inferred relationship Some 1
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Codeine phosphate true Inferred relationship Some 1
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 1
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient Paracetamol true Inferred relationship Some 2
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) Paracetamol true Inferred relationship Some 2
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit (attribute) Capsule (unit of presentation) true Inferred relationship Some 2
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation Capsule (unit of presentation) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start